Skip to main content

Is Prevention Possible? Antibiotic Prophylaxis for Recurrent Lower Extremity Cellulitis



Case
As a geriatrician it is not uncommon to have patients present in clinic with signs of infection like cellulitis, an infection of the skin. My patient, who I will call Mr. Sa, is a 79 year old man with a history of hypertension, high cholesterol, and COPD who struggled with recurrent cellulitis of his right lower leg. Despite two prior clinic visits and completed courses of antibiotics, the infection would heal but return several months later.

Clinical Question
In patients with recurrent lower extremity cellulitis, do prophylactic antibiotics, compared to no treatment, reduce the recurrence rate of lower extremity cellulitis?

Best Available Evidence
A search of the literature found a systemic review and meta-analysis of antibiotic prophylaxis for preventing recurrent cellulitis1. The systemic review used the Cochrane Collaboration tool for assessing the risk of bias and the meta-analysis was used to calculate a weighted treatment effect across trials. Five studies met the inclusion criteria resulting in a total of 535 participants with 260 participants taking antibiotics and 275 participants on placebo or not taking any antibiotics. The average age of participants in the five studies ranged from 45 to 67.5 years. A majority of the participants (397) were from the PATCH 1 and 2 studies located in the United Kingdom with a follow up time of 36 months. Statistical methods calculated included risk ratio, Chi2, and I2 tests.

Results
Analysis revealed that prophylactic antibiotics were beneficial for preventing recurrent cellulitis (RR 0.46, 95% CI 0.26-0.79) with a number needed to treat (NNT) of 5 patients. This means that 5 patients would need to receive the prophylactic antibiotics in order to benefit 1 patient (in preventing recurrent cellulitis).

Appraisal
It should be noted that two of the studies (PATCH 1 and 2) were found to be high quality whereas three of the studies were of low or unclear quality with respect to randomization, allocation concealment, blinding, incomplete outcome data, and selective reporting. Overall limitations include a small number of studies performed in the United Kingdom, a heterogeneous study population among subjects, optimal duration of treatment was non-specified, and finally specific antibiotic medication choice (erythromycin or penicillin) varied across the studies. The most commonly reported adverse events with prescribing prophylactic antibiotics were nausea, abdominal pain, and diarrhea. These limitations hinder the generalizability of the study results, especially with varying antibiotic resistances profiles dependent on location.

The review supports the positive impact of antibiotics for prophylaxis against recurrent cellulitis in the United Kingdom. However, there needs to be more randomized controlled trials set in the United States to determine the applicability, specific antibiotic choice, and optimal duration of treatment.

Back to our Patient
For Mr. Sa, prophylactic antibiotics were not prescribed for cellulitis prevention given his allergy to Penicillin antibiotics. However, for future patients who struggle with recurrent cellulitis, the low NNT and low risk of side effects makes prescribing prophylactic antibiotic a treatment to consider.

Reference:
1. Oh, C.C., Ko, H.C.H, et al. (2014). Antibiotic prophylaxis for preventing recurrent cellulitis: A systemic review and meta-analysis. Journal of Infection, 69, 26-34.

By: Megan E. Rau, MD, MPH
@meganerau
Megan is currently a first year fellow in Geriatrics and Palliative Care at Mount Sinai Hospital in New York City.

This post is part of the #GeriCases series, in which we discuss a clinical case in geriatrics and palliative medicine and the attempt to provide patient-centered care with the use of best available evidence.

Ravishankar Ramaswamy, MD
@RavRamaswamy
Section Editor, #GeriCases

Comments

By reading this I hope this situation is easily curable. Now the over all world temperature is increasing and people are suffering with the problem like this.

Popular posts from this blog

Practical Advice for the End of Life: A Podcast with BJ Miller

This week we talk with BJ Miller, hospice and palliative care physician, public speaker, and now author with Shoshana Berger of the book "A Beginner's Guide to the End."

As we note on the podcast, BJ is about as close as we get to a celebrity in Hospice and Palliative Care.  His TED Talk "What Really Matters at the End of Life" has been viewed more than 9 million times.  As we discuss on the Podcast, this has changed BJ's life, and he spends most of his working time engaged in public speaking, being the public "face" of the hospice and palliative care movement.

The book he and Berger wrote is filled to the brim with practical advice.  I mean, nuts and bolts practical advice.  Things like:
How to clean out not only your emotional house but your physical house (turns out there are services for that!)Posting about your illness on social media (should you post to Facebook)What is the difference between a funeral home and mortuaryCan I afford to die?  …

Improving Advance Care Planning for Latinos with Cancer: A Podcast with Fischer and Fink

In this week's GeriPal podcast we talk with Stacy Fischer, MD and Regina Fink, RN, PhD, both from the University of Colorado, about a lay health navigator intervention to improve advance care planning with Latinos with advanced cancer.  The issue of lay health navigators raises several issues that we discuss, including:
What is a lay health navigator?What do they do?  How are they trained?What do lay health navigators offer that specialized palliative care doesn't?  Are they replacing us?What makes the health navigator intervention particularly appropriate for Latinos and rural individuals?  For advance care planning? Eric and I had fun singing in French (yes French, not Spanish, listen to the podcast to learn why).
Enjoy! -@AlexSmithMD




You can also find us onYoutube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher

Transcript

Eric: Welcome to the GeriPal podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: And Alex, I'm really excited about toda…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …